AMSTERDAM — Two small studies failed to detect any functional improvement from the use of intranasal oxytocin (multiple brands) in patients with schizophrenia, even when coupled with social skills training, research presented here indicates.
“The hypothesis was that oxytocin would increase understanding of emotions, empathy, and facial expression and that the combination of oxytocin and social skills training would bring the highest level of improvement,” Mark Weiser, MD, chairman of psychiatry, Tel Aviv University, Israel, told delegates.
“But the bottom line was in our hands ― in these patients, oxytocin was not efficacious in improving social function in schizophrenia.”
http://www.medscape.com/viewarticle/850411
To access Medscape without registering try http://bugmenot.com/
